Pelthos Therapeutics Inc.

New Filing
CIK: 0001919246·Pharmaceuticals·NEVADA·Filed: Nov 19, 2025
Total Offering

$18,000,000

Amount Sold

$18,000,000

Investors

8

First Sale

Nov 6, 2025

Offering Details

Type
Option to Acquire, Security to be Acquired, Other: Senior secured convertible notes, which are convertible into shares of the Company's common stock, par value $0.0001 per share.
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2021
Non-Accredited Investors
No

Related Persons

NameRole
Francis Knuettel II
Related Person
Richard Malamut
Related Person
Scott Plesha
Related Person
Richard Baxter
Related Person
Ezra Friedberg
Related Person
Todd Davis
Related Person
Peter Greenleaf
Related Person
Matthew Pauls
Related Person
Sai Rangarao
Related Person

Company

Pelthos Therapeutics Inc.

4020 STIRRUP CREEK DRIVE

DURHAM, NC, 27703

919-908-2400

SEC Filing

0001919246-25-000006

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free